Literature DB >> 23354652

The incidence and significance of multiple lesions in glioblastoma.

Reena P Thomas1, Linda W Xu, Robert M Lober, Gordon Li, Seema Nagpal.   

Abstract

The location and distribution of glioblastoma (GBM) within the brain parenchyma plays an important role in surgical and radiation planning. Prior studies have reported incidences of multiple lesions at the time of diagnosis ranging from 0.5 to 20 %. Multiple lesions can be further categorized as multifocal (multiple areas involved, but with a clear path of spread from one lesion to another) or multicentric (multiple lesions, no clear path of spread). In this retrospective study, we reviewed our experience with GBM and found the incidence of multiple lesions at time of diagnosis was 35 %, much higher than previously suggested in the literature. Patients with single lesions had an improved overall survival when compared to patients with multiple lesions (18 vs. 10 months). Patients with multicentric lesions fared the worst, with average survival of 3 months. However, the difference between single and multiple lesions (multifocal or multicentric) was no longer significant when taking into consideration age, Karnofsky performance score (KPS) and extent of resection by multivariate analysis. Age, KPS, gross total resection, and MGMT status were independent predictors of outcome. Multiple lesions did not independently confer a worse outcome, but were associated with lower KPS scores and inability to perform gross total resection. These findings suggest that single, multiple and multicentric imaging exams represent a spectrum of presentations of a single disease. The rate of multiple lesions reported here may be the result of improved imaging technology, suggesting that incidence of multiple lesions will continue to increase as imaging technology advances.

Entities:  

Mesh:

Year:  2013        PMID: 23354652     DOI: 10.1007/s11060-012-1030-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  10 in total

1.  Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients.

Authors:  Andreas M Stark; Julia van de Bergh; Jürgen Hedderich; H Maximilian Mehdorn; Arya Nabavi
Journal:  Clin Neurol Neurosurg       Date:  2012-02-27       Impact factor: 1.876

2.  Imaging patterns of multifocal gliomas.

Authors:  A P Kyritsis; V A Levin; W K Yung; N E Leeds
Journal:  Eur J Radiol       Date:  1993-04       Impact factor: 3.528

3.  The incidence of multifocal cerebral gliomas. A histologic study of large hemisphere sections.

Authors:  R O Barnard; J F Geddes
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

Review 4.  Diagnosis and management of multifocal gliomas.

Authors:  Sotirios Giannopoulos; Athanassios P Kyritsis
Journal:  Oncology       Date:  2011-03-17       Impact factor: 2.935

5.  Radiographic incidence of multicentric malignant gliomas.

Authors:  H R Djalilian; M V Shah; W A Hall
Journal:  Surg Neurol       Date:  1999-05

6.  Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article.

Authors:  Wael Hassaneen; Nicholas B Levine; Dima Suki; Abhijit L Salaskar; Alessandra de Moura Lima; Ian E McCutcheon; Sujit S Prabhu; Frederick F Lang; Franco DeMonte; Ganesh Rao; Jeffrey S Weinberg; David M Wildrick; Kenneth D Aldape; Raymond Sawaya
Journal:  J Neurosurg       Date:  2010-08-06       Impact factor: 5.115

7.  Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults.

Authors:  Andrew T Parsa; Scott Wachhorst; Kathleen R Lamborn; Michael D Prados; Michael W McDermott; Mitchel S Berger; Susan M Chang
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

8.  Glioblastoma Stem Cells: A Neuropathologist's View.

Authors:  Roger E McLendon; Jeremy N Rich
Journal:  J Oncol       Date:  2010-11-01       Impact factor: 4.375

9.  Prognosis of patients with multifocal glioblastoma: a case-control study.

Authors:  Chirag G Patil; Anthony Yi; Adam Elramsisy; Jethro Hu; Debraj Mukherjee; Dwain K Irvin; John S Yu; Serguei I Bannykh; Keith L Black; Miriam Nuño
Journal:  J Neurosurg       Date:  2012-08-24       Impact factor: 5.115

10.  Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype.

Authors:  Daniel A Lim; Soonmee Cha; Mary C Mayo; Mei-Hsiu Chen; Evren Keles; Scott VandenBerg; Mitchel S Berger
Journal:  Neuro Oncol       Date:  2007-07-10       Impact factor: 12.300

  10 in total
  29 in total

1.  The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma.

Authors:  Arian Lasocki; Frank Gaillard; Mark A Tacey; Katharine J Drummond; Stephen L Stuckey
Journal:  J Neurooncol       Date:  2016-07-13       Impact factor: 4.130

2.  Gliomatosis cerebri type 1 with extensive involvement of the spinal cord and BRAF V600E mutation.

Authors:  Ivan Fernandez-Vega; Jennifer Quirk; Fiona L Norwood; Naomi A Sibtain; Ross Laxton; Istvan Bodi
Journal:  Pathol Oncol Res       Date:  2013-12-19       Impact factor: 3.201

3.  MR Fingerprinting of Adult Brain Tumors: Initial Experience.

Authors:  C Badve; A Yu; S Dastmalchian; M Rogers; D Ma; Y Jiang; S Margevicius; S Pahwa; Z Lu; M Schluchter; J Sunshine; M Griswold; A Sloan; V Gulani
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-29       Impact factor: 3.825

4.  Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.

Authors:  Pattana Wangaryattawanich; Masumeh Hatami; Jixin Wang; Ginu Thomas; Adam Flanders; Justin Kirby; Max Wintermark; Erich S Huang; Ali Shojaee Bakhtiari; Markus M Luedi; Syed S Hashmi; Daniel L Rubin; James Y Chen; Scott N Hwang; John Freymann; Chad A Holder; Pascal O Zinn; Rivka R Colen
Journal:  Neuro Oncol       Date:  2015-07-22       Impact factor: 12.300

5.  Molecular image-directed biopsies: improving clinical biopsy selection in patients with multiple tumors.

Authors:  Stephanie A Harmon; Michael J Tuite; Robert Jeraj
Journal:  Phys Med Biol       Date:  2016-10-03       Impact factor: 3.609

6.  Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma.

Authors:  Anna K Paulsson; Jordan A Holmes; Ann M Peiffer; Lance D Miller; Wennuan Liu; Jianfeng Xu; William H Hinson; Glenn J Lesser; Adrian W Laxton; Stephen B Tatter; Waldemar Debinski; Michael D Chan
Journal:  J Neurooncol       Date:  2014-07-03       Impact factor: 4.130

7.  Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.

Authors:  Qun Liu; Yuexin Liu; Wenliang Li; Xiaoguang Wang; Raymond Sawaya; Frederick F Lang; W K Alfred Yung; Kexin Chen; Gregory N Fuller; Wei Zhang
Journal:  Acta Neuropathol       Date:  2015-09-01       Impact factor: 17.088

Review 8.  Trends and outcomes in the treatment of gliomas based on data during 2001-2004 from the Brain Tumor Registry of Japan.

Authors:  Yoshitaka Narita; Soichiro Shibui
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-03-23       Impact factor: 1.742

9.  Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.

Authors:  Claudia R Oliva; Tahireh Markert; G Yancey Gillespie; Corinne E Griguer
Journal:  Oncotarget       Date:  2015-02-28

Review 10.  Cancer Metastases: Early Dissemination and Late Recurrences.

Authors:  Sten Friberg; Andreas Nyström
Journal:  Cancer Growth Metastasis       Date:  2015-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.